Ruijian Med Secures $29M for AI-Driven Cell Therapy
Ruijian Medicine raises 210M RMB to advance its AI-driven chemical induction platform and global cell therapy pipelines.
1 articles about 'Ruijian Medicine'
Ruijian Medicine raises 210M RMB to advance its AI-driven chemical induction platform and global cell therapy pipelines.